Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-372-6 | CAS number: 98730-04-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
oral LD50 >5000 mg/kg, (Argus et al, 1986).
dermal LD50 >2010 mg/kg, (Taberski et al., 1986).
inhalation LC50 >2000 mg/m3, 4 hour, (Taberski et al., 1986).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 February 1986 to 20 February 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Groups of 5 male and 5 female young adult Sprague Dawley rats.
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- The test article was dissolved in 1% carboxy methylcellulose and a volume of 50 ml/kg was administered.
- Doses:
- 0, 100, 500, 1000, 2500, or 5000 mg/kg CGA154281
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- The animals were observed for 14 days and deaths, clinical signs and body weights were recorded.
- Statistics:
- Not reported.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: based on 20% mortality in males (only) at 5000 mg/kg
- Mortality:
- One male dosed with 5000 mg/kg died on day 4.
- Clinical signs:
- other: Signs of systemic toxicity were observed at dose levels > 500 mg/kg and included hypoactivity, perineal staining, soft feces, and squinting. At dose levels > 2500 mg/kg, chromodacryorrhea, staining around the mouth and few feces were noted additionally. A
- Gross pathology:
- At necropsy, no treatment-related findings were observed.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results of this study, the LD50 was determined to be greater than 5000 mg/kg.
- Executive summary:
Single oral doses of 100, 500, 1000, 2500 or 5000 mg/kg of benoxacor (CGA154281) were administered by gavage to groups of 5 male and 5 female rats. There were no clinical signs at 100 mg/kg. Signs of toxicity were apparent at doses of 500 mg/kg or greater. One of five males died at the 5000 mg/kg dose level. There were no other mortalities. The median lethal dose was greater than 5000 mg/kg in both sexes. Benoxacor was considered to be of low toxicity when given as a single oral dose to rats.
Reference
There were no clinical findings at 100 mg/kg. Clinical signs of toxicity were apparent at doses of 500 mg/kg or greater. At the high dose 5000 mg/kg one of five males died (20% mortality). There were no other deaths.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- One reliable study is available.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 February 1986 to 6 March 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-3 (Acute inhalation toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Two groups of 8 to 10 week old Sprague Dawley rats (5 animals/sex).
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- The test material was supplied as a powder and tested as received. The test atmosphere was generated using a Teost Air Mill fed via a revolving disc driven by a Sage motor. The chamber concentration was controlled by adjusting generator conditions.
The gravimetric chamber concentrationd of the test substance was determined hourly from samples collected by means of an
open-faced filter placed near the breathing zone of the animals. The nominal chamber concentratione was also calculated. Particle size analyses were conducted on hourly samples taken from the chamber using a Sierra cascade impactor. The mass median diameter and its geometric standard deviation were derived from a log-normal plot of cumulative mass of test substance deposited on each successive stage of the impactor against the stage's effective cut-off size diameter.
The hourly gravimetric chamber concentrations for Group 2 ranged from 1.9 to 2.1 mg/L with a 4-hour average value of 2.0 mg/L.
The hourly mass median diameter (MMD) and geometric standard deviation for the test atmosphere ranged from from 7.2 to 13.0 µm. (geometric SD = 2.2 to 2.6). Approximately 51% of the particles collected had an equivalent aerodynamic diameter of less than or equal to 9 µm.
Animals were exposed to control air or to 2000 mg/m3 CGA 154281 for 4 consecutive hours. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- measured every hour and ranged from 1.9 to 2.1 mg/L.
- Duration of exposure:
- 4 h
- Concentrations:
- 2000 mg/m3
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- 14 days observation period with observations of mortality, clinical signs and bodyweight. Gross pathology examination of animals at termination.
- Statistics:
- Not applicable.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 2 000 mg/m³ air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- other: based on 100% survival at the highest dose tested
- Mortality:
- No mortality was observed during the 14-day observation period.
- Clinical signs:
- other: Control animals were asymptomatic. In treated animals lacrimation, chromodacryorrhea, rhinorrhea, chromorhinorrhea, red stains around the facial area, salivation, dehydration, anorexia and few feces were observed. All rats recovered within 7 days.
- Body weight:
- Body weight gain was comparable between the groups.
- Gross pathology:
- At necropsy, no treatment-related findings were recorded. Mean lung weights of treated animals were comparable to the control values.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results of the study the inhalation LC50 for a 4 hour exposure period was determined to be greater than 2000 mg/m3.
- Executive summary:
Male and female rats were exposed, whole body, for 4 hours to an atmosphere containing benoxacor (CGA154281 Technical) at a concentration of 2.0 mg/L (MMD = 9.0 µm, GSD = 2.3). All rats survived treatment. Clinical signs were observed.
Based on the absence of signs of toxicity in the limit exposure conditions, benoxacor is considered to be of low acute inhalation toxicity and the median lethal dose was found to exceed 2 mg/L air.
Reference
All rats survived treatment and only mild clinical signs were observed.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- One reliable study is available.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 January 1986 to 27 January 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-2 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: H.A.R.E. Inc Hewitt NJ, USA
- Age at study initiation: 12-14 weeks
- Weight at study initiation: 2.5 to 3.5 kg
-
- Housing:
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period: 3 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): standard laboratory conditions
- Humidity (%): standard laboratory conditions
- Air changes (per hr): standard laboratory conditions
- Photoperiod (hrs dark / hrs light): standard laboratory conditions
IN-LIFE DATES: From: 13.01.1986 To: 27.01.1986 - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- The test material was moistened with water and applied to the shaved skin. It was covered by a gauze pad, which was held in place for 24 hours with a tape. Thereafter the material was removed with tap water. Collars prevented the rabbits from ingesting the test article.
- Duration of exposure:
- 24 hours
- Doses:
- 2010 mg/kg
- No. of animals per sex per dose:
- 5 male and 5 female
- Control animals:
- no
- Details on study design:
- Two week observation period. Clinical signs and bodyweights recorded.
- Statistics:
- Not applicable.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 010 mg/kg bw
- Remarks on result:
- other: No notable effects on any parameters at limit dose level
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: No signs of systemic toxicity were recorded; however, a slight erythema was noted in one male on test day two.
- Gross pathology:
- At necropsy, no remarkable findings were noted.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results of this study, the dermal LD50 was determined to be greater than 2010 mg/kg.
- Executive summary:
A single dose of 2010 mg benoxacor /kg bw was administered topically to a group of five male and five female NZW rabbits.
No notable clinical signs were observed. One male had a slight erythematous dermal response on day 2 but otherwise there were no changes indicative of dermal irritation or systemic toxicity. No mortalities occurred and the median lethal dose was found to exceed 2010 mg/kg bw. Benoxacor (CGA154281 Technical) was found to be of low toxicity when applied topically to rabbit skin on a single occasion.
Reference
No notable clinical signs were observed. One male had a slight erythematous dermal response on day 2 but otherwise there were no changes indicative of derrmal irritation or systemic toxicity.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- One reliable study is available.
Additional information
Guideline- and GLP-compliant acute toxicity studies are available for the test item administered by the oral, inhalation and dermal routes of exposure.
Acute oral toxicity data for benoxacor indicate an oral LD50 value in rats of >5000 mg/kg (Argus et al, 1986).
A four hour acute inhalation toxicity study in rats showed no acute inhalation toxicity at an exposure concentration of 2 mg/L (2000 mg/m3, Taberski et al., 1986).
An acute dermal toxicity study gave an acute dermal LD50 value in rabbits of >2010 mg/kg (Taberski et al., 1986).
Justification for selection of acute toxicity – oral endpoint
The study is compliant with GLP and guidelines and demonstrated reliably the low oral acute toxicity of benoxacor with an LD50 >5000 mg/kg bw. One male animal died at the highest dose of 5000 mg/kg bw, whereas no mortality occurred at doses equal to or less than 2500 mg/kg bw.
Justification for selection of acute toxicity – inhalation endpoint
The study is compliant with GLP and guidelines and demonstrated reliably the low inhalation acute toxicity of benoxacor with an LC50 >2000 mg/m3.
Justification for selection of acute toxicity – dermal endpoint
The study is compliant with GLP and guidelines and demonstrated reliably the low dermal acute toxicity of benoxacor with an LD50 >2010 mg/kg bw.
Justification for classification or non-classification
Acute toxicity studies are available for the test item administered by the oral, inhalation and dermal routes of exposure. All the available studies are considered adequate and reliable for the purposes of risk assessment, classification and labelling. The three studies produced effect levels that are greater than the relevant cut-off values triggering classification via the different routes of exposure.
The results do not lead to classification according to Directive 67/548/EEC or according to Regulation (EC) No. 1272/2008 as amended by Commission Regulation (EU) No. 286/2011.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)